Compare CRUS & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRUS | CAI |
|---|---|---|
| Founded | 1984 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.0B |
| IPO Year | 1997 | N/A |
| Metric | CRUS | CAI |
|---|---|---|
| Price | $130.49 | $18.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $149.60 | $33.67 |
| AVG Volume (30 Days) | 588.8K | ★ 2.1M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.45 | N/A |
| EPS | ★ 6.27 | N/A |
| Revenue | ★ $1,896,077,000.00 | N/A |
| Revenue This Year | $6.11 | $24.26 |
| Revenue Next Year | $1.64 | $22.60 |
| P/E Ratio | $21.49 | ★ N/A |
| Revenue Growth | ★ 5.99 | N/A |
| 52 Week Low | $75.83 | $17.15 |
| 52 Week High | $146.88 | $42.50 |
| Indicator | CRUS | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 36.35 |
| Support Level | $114.49 | $17.15 |
| Resistance Level | $135.39 | $21.47 |
| Average True Range (ATR) | 4.38 | 1.28 |
| MACD | -1.94 | 0.15 |
| Stochastic Oscillator | 4.75 | 32.96 |
Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.